Announcements - APOL

Date Name Options
17/06/22  |  13:23Apollon Formularies - Issue of EquityView item
05/05/22  |  12:07Apollon Formularies - Apollon Acquires Intellectual Property from AionView item
02/03/22  |  07:00Apollon Formularies - Joint Venture with Tri-Medi Canna, South AfricaView item
09/02/22  |  07:00Apollon Formularies - Intention to Join OTC & Migrate to Larger ExchangeView item
03/02/22  |  07:00Apollon Formularies - Grand Opening of International Cancer InstituteView item
27/01/22  |  07:01Apollon Formularies - Chief Science Officer Appointed as Board DirectorView item
25/01/22  |  07:00Apollon Formularies - CEO Review of 2021View item
21/01/22  |  11:19Apollon Formularies - Non-Board Clinical Trial Director AppointmentView item
12/01/22  |  07:00Apollon Formularies - Appointment of Non-Executive DirectorView item
10/01/22  |  07:00Apollon Formularies - Tripartite Agreements with Licensed CultivatorsView item
06/01/22  |  10:25Apollon Formularies - Approval of Medical Cannabis License RenewalsView item
15/12/21  |  07:00Apollon Formularies - Completion of High-Volume Processing LaboratoryView item
09/12/21  |  07:00Apollon Formularies - First Cancer Patients TreatedView item
02/12/21  |  16:00Apollon Formularies Plc - Result of AGMView item
03/11/21  |  12:05Apollon Formularies - Notice of AGMView item
30/09/21  |  16:08Apollon Formularies - Interim ResultsView item
15/09/21  |  07:00Apollon Formularies - Substantial Increase to Production CapacityView item
30/07/21  |  08:00Apollon Formularies - Extension of Right to Purchase on CBev VenturesView item
21/07/21  |  07:00Apollon Formularies - Senior Appointment AnnouncementView item
19/07/21  |  07:00Apollon Formularies - Apollon Formulations Kill Prostate Cancer CellsView item
15/07/21  |  07:00Apollon Formularies - Appointment of Medical DirectorView item
01/07/21  |  07:00Apollon Formularies - Extension of Right to Purchase on Doc’s PlaceView item
30/06/21  |  16:46Apollon Formularies - Annual Report for Year Ended 31 December 2020View item
28/06/21  |  07:00Apollon Formularies - Apollon Formulations Kill TNBC CellsView item
14/06/21  |  07:00Apollon Formularies - Apollon Secures Cancer Treatment FacilityView item
27/05/21  |  07:05Apollon Formularies - Apollon Jamaica Open with COVID-19 CertificationView item
18/05/21  |  07:00Apollon Formularies - Combined Formulations Kill Breast Cancer CellsView item
12/05/21  |  13:42Apollon Formularies Plc - Holding(s) in CompanyView item
21/04/21  |  13:57Apollon Formularies Plc - Holding(s) in CompanyView item
13/04/21  |  07:00Apollon Formularies Plc - Admission to Trading on AQSE and Apollon Ltd ConsentView item
12/04/21  |  16:22AfriAg Global Plc - Result of GM and AQSE Regulatory Approval for ApollonView item
07/04/21  |  11:00AfriAg Global Plc - Posting of Supplementary Admission DocumentView item
19/03/21  |  07:00AfriAg Global Plc - Notice of GM for Apollon AcquisitionView item
23/02/21  |  07:00AfriAg Global Plc - Proposed RTO, Re-Admission to AQSE and £2.5M RaiseView item
12/01/21  |  14:56AfriAg Global Plc - Change of AuditorView item
17/11/20  |  09:41AfriAg Global Plc - Apollon’s Stephen Barnhill Prohibition Partners LiveView item
03/11/20  |  13:16AfriAg Global Plc - Result of AGMView item
07/09/20  |  08:12Result of AGMView item
04/08/20  |  11:53Notice of AGMView item
28/07/20  |  16:37Change of Registered OfficeView item
21/07/20  |  09:40Unaudited Results for the six months to 30 June 2020View item
15/07/20  |  16:46Results for the Year Ended 31 December 2019View item
29/11/19  |  07:12Disposal of African business and TVRView item